DLA Piper Partner Jeff Selman By Jarrett Banks 2020 has meant a lot of things to different people. But for Jeff Selman, a partner at DLA Piper, who advises […]

NEW YORK–(BUSINESS WIRE)–Ajax I (the “Company” or “Ajax”) announced today the pricing of its initial public offering of 75,000,000 units, at a price of $10.00 per unit. The units will […]

NEW YORK–(BUSINESS WIRE)–October 27, 2020 — Atlas Crest Investment Corp. (NYSE: ACIC.U, the “Company”) announced today that it priced its initial public offering of 50,000,000 units at a price to […]

  By Jarrett Banks Matt Rubel is looking to empower a business. The former CEO of Cole Haan just launched a retail-focused SPAC called Empower Ltd. (NYSE: EMPW-UN), which raised […]

  By John Jannarone Funding for therapeutic medicine can be controversial, especially in the case of psilocybin. To address recent investor questions, IPO Edge spoke Wednesday with Mydecine Innovations Group, […]

NORWALK, Conn.–(BUSINESS WIRE)–Datto Holding Corp. (“Datto”), (NYSE: MSP) the leading global provider of cloud-based software and technology solutions purpose-built for delivery by managed service providers (MSPs), today announced the pricing […]

GREENWICH, Conn.–(BUSINESS WIRE)–Horizon Acquisition Corporation II (the “Company”), a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or […]

    Akerna Founder and CEO Jessica Billingsley By Jarrett Banks Being a female CEO in tech and the even less diverse cannabis industry is no small feat. But Akerna […]

By John Jannarone 22nd Century Group, Inc. (ticker: XXII) wants you to quit smoking. But it also wants you to feel better. The biotechnology company is primarily focused on reduced […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Codiak BioSciences, Inc. (“Codiak”), a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the pricing of its initial […]